Article

Activities turn research into treatment

The Association for Research in Vision and Ophthalmology works closely with the National Alliance for Eye and Vision Research to help ensure that adequate funding is available for both basic and translational research for the National Eye Institute.

2010 NEI/FDA endpoints symposium

Can measures of structural change correlate to visual function, then serve as endpoints in clinical studies to support the approval of new drug and device diagnostics and therapies for glaucoma?

These symposia demonstrate NEI's leadership in translational research, as recognized by NIH Director Francis Collins, MD, PhD, during NEI's 40th anniversary celebration this year.

"The NEI has been central to advances in translational research," Dr. Collins said. "Its vision has allowed us to see farther and better and has enabled the NIH to attain its vision. Most importantly, the best is yet to come."

TMAT Working Group

Dr. Collins has identified translational research as one of his top five NIH priorities. The Translational Medicine and Therapeutics (TMAT) Working Group will lead the charge to develop a comprehensive translational research strategy.

The TMAT Working Group held 2 days of discussions in September with stakeholders about how the NIH currently coordinates its numerous initiatives regarding clinical and translational research-internally and with other Department of Health and Human Services (HHS) agencies, such as the FDA; other government agencies; the private biomedical research sector; and the patient and advocacy community.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
© 2025 MJH Life Sciences

All rights reserved.